Chinese vaccine draws demand across Latin America, say Brazilian officials
By Ana Mano and Eduardo Simões SAO PAULO (Reuters) - Doses of a COVID-19 vaccine made by China's Sinovac Biotech are rolling off a Brazilian production line, drawing interest around the country and across Latin America from governments struggling to procure costlier vaccines. Sao Paulo Governor Joao Doria said at a news conference on Thursday that the state's biomedical center, the Butantan Institute, aims to fill and finish 1 million doses per day on its production line for a vaccination campaign to start Jan.
By Ana Mano and Eduardo Simões
SAO PAULO (Reuters) - Doses of a COVID-19 vaccine made by China's Sinovac Biotech are rolling off a Brazilian production line, drawing interest around the country and across Latin America from governments struggling to procure costlier vaccines.
Sao Paulo Governor Joao Doria said at a news conference on Thursday that the state's biomedical center, the Butantan Institute, aims to fill and finish 1 million doses per day on its production line for a vaccination campaign to start Jan. 25.
Doria said 11 Brazilian states have contacted Butantan seeking the doses of the vaccine, called CoronaVac, setting up a showdown with President Jair Bolsonaro, who has said he refuses to buy the Chinese vaccine for a national immunization program.
At the same news conference, Butantan head Dimas Covas said several countries in the region, including Peru, Uruguay, Paraguay and Honduras are interested in buying the CoronaVac vaccine from Brazil. Butantan is in advanced talks with Argentina to the supply vaccine, he said.
Dimas said CoronaVac doses would cost $10.30 to Brazilian states and cities outside of Sao Paulo, a fraction of what U.S. and European pharmaceutical companies are charging for COVID-19 vaccines.
Butantan has begun to build a facility where it plans to produce the vaccine from scratch as of September 2021 instead of receiving it in bulk from China to fill and label vials.
Earlier on Thursday, Health Minister Eduardo Pazuello pledged in a radio interview to vaccinate Brazil's entire population against COVID-19 next year. Pressure has been mounting, with state governors criticizing the federal government as unprepared for a mass immunization campaign and failing to secure a diverse enough supply of vaccines.
Pazuello repeated the ministry would buy any effective vaccines that are approved by health regulator Anvisa and reasonably priced, opening the door to a federal purchase of the Chinese vaccine.
Brazil has the world's second-deadliest outbreak of the novel coronavirus after the United States, with more than 178,000 deaths. The continent-sized country, with a population of 212 million, has registered 6.7 million confirmed cases.
Although Brazil has an enviable record for national vaccination campaigns and a strong public health system, Bolsonaro has repeatedly denied the gravity of the virus and is a vaccine skeptic who has said he will not take a COVID-19 shot.
On Thursday, Bolsonaro said the end of the pandemic was in sight for Brazil, despite a worsening second wave of infections, with daily case numbers back to mid-August levels.
"Our country is among those that have best emerged from the pandemic," he said at a public event without providing evidence.
Also on Thursday, health regulator Anvisa set out rules for companies to apply for emergency use authorizations for COVID-19 vaccines, an option that had not previously existed.
The Anvisa decision could allow emergency use of vaccines being tested in Brazil. AstraZeneca, Pfizer Inc, Johnson & Johnson's pharmaceutical subsidiary Janssen, and Sinovac all have vaccines in late-stage trials.
The federal government has signed a letter of intent to buy 70 million doses from Pfizer as well as around 100 million doses from AstraZeneca. In total, it says it has lined up 300 million doses via agreements with several manufacturers.
(Reporting by Eduardo Simões and Ana Mano, writing by Anthony Boadle, editing by David Gregorio and Grant McCool)
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States
BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.